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  1 
Summary 
Objective: Determine the absorption characteristics of transdermal fentanyl and 
buprenorphine in swine. 
Methods: 24 Yorkshire gilts, (± 27.8 ± 2.2 kg), were randomly assigned to different doses 
of transdermal patches (TP) of fentanyl (50, 75 and 100 μg/h) or buprenorphine (35 and 
70 μg/h), once or twice. 13 blood samples were obtained for each TP applied. Plasma 
concentrations, area under the curve, peak serum concentration (Cmax) and time to Cmax 
were obtained. 
Results: Fentanyl: Cmax were observed at different time points for the first TP: 30 h for 
50 μg/h, 6 h for 75 μg/h and 100 μg/h; and for the second TP: 30 h for 50 μg/h; 36 h for 
75 μg/h. Buprenorphine: serum concentrations were not detected for the 35 μg/h TP; 
Cmax was observed at different times for the 70 μg/h patch: 18 h (n = 1), 24 h (n = 3), 30 
h (n = 1) and 42 h (n = 1) after application for the first TP and 12 h after the second TP. 
Conclusion: Relevant serum concentrations obtained with 75 or 100 μg/h fentanyl TP 
suggests they could represent an analgesia option for the laboratory pig weighing 25-30 
kg. As concentrations of buprenorphine were variable, this study does not support the use 
of buprenorphine TP in pigs. Consecutive fentanyl or buprenorphine TPs did not provide 
reliable serum concentrations. Further pharmacokinetics studies and analgesiometric tests 
in swine are needed to confirm the clinical adequacy of transdermal patches. 






Methoden: 24 Yorkshire-Jungsauen, (27,8 ± 2,2 kg), wurden randomisiert verschiedene 
Dosierungen Transdermaler Pflaster (TP) mit Fentanyl (50, 75 und 100 μg / h) oder 
Buprenorphin (35 und 70 μg / h) ein- oder zweimalig zugewiesen. 13 Blutproben wurden 
für jedes angewandte TP entnommen. Die Plasmakonzentrationen, die Cmax und die Zeit 
bis Cmax wurden ermittelt. 
Ergebnisse: Fentanyl: Cmax wurden zu verschiedenen Zeitpunkten für den ersten TP 
beobachtet: 30 h für 50 μg/h, 6 h für 75 μg/h und 100 μg/h; Und für das zweite TP: 30 h 
für 50 μg/h; 36 h für 75 μg/h. Buprenorphin: Serumkonzentrationen wurden für das 35 
μg/h TP nicht nachgewiesen; Cmax für den 70 μg/h Patch messbar: 18 h (n = 1), 24 h (n 
= 3), 30 h (n = 1) und 42 h (n = 1) nach dem ersten TP und 12 h nach dem zweiten TP. 
Diskussion: Serumkonzentrationen, die mit 75 oder 100 μg/h Fentanyl TP erhalten 
wurden, deuten darauf hin, dass sie eine Analgesie-Option für das Laborschwein mit 
einem Gewicht von 25-30 kg darstellen könnten. Da die Konzentrationen von 
Buprenorphin hier stark variierten, unterstützen diese Ergebnisse die Verwendung von 
Buprenorphin TP bei Schweinen nicht. Aufeinanderfolgende Fentanyl- oder 
Buprenorphin- TPs lieferten keine zuverlässigen Serumkonzentrationen. Weitere 
pharmakokinetische Studien und analgesiometrische Tests in Schweinen sind 
erforderlich, um die klinische Wirksamkeit von TPs zu bestätigen. 
Stichworte: Analgesie, Fentanyl, Buprenophin, Jungsauen, Transdermales Pflaster 
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Objective To determine the absorption characteristics of fentanyl and buprenorphine 
administered transdermally in swine. 
Study design Randomized comparative experimental  trial. 
 
Animals Twenty-four Yorkshire gilts weighing mean ± standard deviation 27.8 ± 2.2 kg. 
Methods Animals were randomly assigned to different doses of transdermal patches (TP) of 
fentanyl (50 µg hour-1, 75 µg hour-1  and 100 µg hour-1) or buprenorphine (35 µg hour-1  and 70 
µg hour-1), once or twice. Thirteen blood samples were obtained for each TP applied. Plasma 
concentrations were determined and the area under the curve, peak serum concentration (Cmax) 
and time to Cmax calculated. 
Results Fentanyl: Cmax were observed at different time points for the first TP application: 30 
hours for 50 µg hour-1, 6 hours for 75 µg hour-1 and 100 µg hour-1; and for the second TP 
application: 30 hours for 50 µg hour-1; 36 hours for 75 µg hour-1. Buprenorphine: serum 
concentrations were not detected for the 35 µg hour-1  patch; Cmax was observed at different  
times for the 70 µg hour-1  patch: 18 hours (n = 1), 24 hours (n = 3), 30 hours (n = 1) and 42  hours 
(n = 1) after application for the first patch and 12 hours after the second  patch. 
 
Conclusion and clinical relevance A relevant serum concentration obtained with fentanyl TP 
dosed at 75 µg hour-1 or 100 µg hour-1 suggests TPs could represent an analgesia option for the 
laboratory pig weighing 25-30 kg. As concentrations of buprenorphine were variable, this study 
does not support the use of buprenorphine TP in pigs. Consecutive fentanyl or  buprenorphine 
TPs did not provide reliable serum concentrations. Further pharmacokinetics studies and 
analgesiometric tests in swine are needed to confirm the clinical adequacy of transdermal 
patches. 
Keywords analgesia, buprenorphine, fentanyl, swine, transdermal  patch. 








The domestic pig (Sus scrofa domesticus) has an important place as a model in biomedical 
research. Many research experiments involve potentially painful interventions, and although pain 
assessment in pigs has been the subject of several publications (Gregoire et al. 2013; Nalon et al. 
2013; Castel et al. 2014; Bradbury et al. 2016), those regarding pain control and analgesic  
efficacy under experimental research conditions are scarce. The evaluation of pain in animals can 
be challenging, but it is accepted that nociception during surgical procedures (e.g. thoracotomies) 
is similar between animals and humans (Livingston 2010; Gigliuto et al. 2014). Therefore, pain 
control is an animal welfare issue and should be addressed in every scientific project involving 
animals (Voipio et al. 2008; Kilkenny et al. 2010; Hawkins et al. 2011; National Research  
Council 2011). 
Opioids such as morphine, fentanyl and buprenorphine are commonly used to control pain in 
veterinary species. Fentanyl is a highly lipophilic pure µ-receptor agonist, that can be 
administered transdermally (by patches or transdermal solution), by mucosal absorption, and 
injectable routes [intramuscular (IM), subcutaneous (SC), intravenous (IV), and neuraxial]. 
Parenteral administration produces a rapid onset but a short duration of action in most animal 
species (Lamont & Mathews 2007), with a reported effect of less than 4 hours in swine (Swindle 
2007). Buprenorphine has been used for many years for treatment of moderate to severe pain in 
humans. It is thought to be a highly lipophilic partial µ-receptor agonist, κ-receptor antagonist 
(Johnson et al. 2005; Cowan 2007), with a longer half-life than both fentanyl and morphine. In 
veterinary practice, parenteral buprenorphine has been used for several decades, and with the 
exception of rare side effects in a small number of animals, it has been proven safe and  
efficacious (Roughan & Flecknell 2002; Coulter et al. 2009). However, maintenance of  analgesia 









with these drugs requires repeated injections, imposing an increased work load for personnel, 
recurring stress for the animal and often results in discontinuity of overnight pain relief. The  
highly liposoluble characteristics of fentanyl and buprenorphine favour their use in transdermal 
administration. Although differences between species and even body sites can be expected, 
transdermal patches (TP) could be an analgesic option for experimental procedures, reducing  
many of the limitations of injectable drugs, while allowing good analgesia for a sustained time 
(Riviere & Papich 2001; Mills et al. 2004). This delivery system is designed to slowly deliver a 
constant drug dose through the skin, reaching therapeutic concentrations after several hours and 
lasting up to three days. TPs are current practice in human medicine and, even though 
controversies exist regarding a proven effect in animals (Hofmeister & Egger 2004; Egger et al. 
2007; Brayden et al. 2010), TPs, especially fentanyl, are popular in veterinary medicine, being a 
recommended method for pain control in many institutions.  Recommendations for use of  
fentanyl TP in pigs are based on few studies, however, wide inter-individual variations and 
variable magnitudes and times to peak plasma concentrations have been reported (Harvey-Clark  
et al. 2000; Wilkinson et al. 2001; Malavasi et al. 2005, 2006; Royal et al. 2013). A single 
publication on use of transdermal buprenorphine in Göttingen minipigs (Thiede et al. 2014) was 
found in a literature search. In view of the paucity of published studies on transdermal 
buprenorphine and the reported unpredictability of transdermal fentanyl in pigs, the possibility of 
species variability and the potential severity of surgical and anaesthetic techniques used under 
experimental conditions, the need for further studies seemed  indicated. 
The aim of this study was to determine the absorption and concentration of fentanyl and 
buprenorphine administered transdermally in pigs. Our hypothesis was that application of  a 
 
 










fentanyl or buprenorphine TP will result in detectable and clinically relevant serum 
concentrations in pigs postoperatively for 3-4 days without the need for  supplementation. 
 
 
Materials and methods 
 
This study was performed between September 2006 and September 2007. The protocol was 
approved by the Ethics Committee of the University Hospital in Geneva, Switzerland and the 
local and Federal Swiss Veterinary Office (no. 31.1.1043/3088/3), according to European 
Community Directives, Federation of Laboratory Animal Science Associations (FELASA) and 
Swiss Federal Regulations. 
 
 
Animals and housing 
 
Good health status of 24 Yorkshire gilts, weighing [mean ± standard deviation (SD)], 27.8 ± 2.2 
kg was confirmed by physical examination by a veterinarian upon arrival to the animal facilities 
at the University Hospital, Geneva, Switzerland. The animals were housed in groups of  three. 
Water was supplied ad libitum and food (Nutriporc growing pigs 25-100 kg feed; Provimi-Kliba 
AG, Switzerland) was provided twice a day, according to their weights. The light:dark cycle was 
12 hours of light and 12 hours of darkness, with a relative humidity of 38% and a temperature of 
22 ºC. Wood blocks and hanging chains were supplied for enrichment. The acclimatization   
period was of three consecutive days. In order to familiarize the animals with the procedures and 
to the handler, the boxes were visited at least three times a day, with the handler progressively 
approaching the animals. The protocol included sitting in the cage for up to 30 minutes, slowly 
progressing to a closer contact. After one day, the observers were able to touch the pigs and  
mimic the blood sampling procedure. 
 
 








Study design and protocol 
 
The study was a prospective randomized comparative experimental trial; the investigators were  
not blinded. Randomization was achieved by drawing pieces of paper out of a box, to assign each 
animal an opioid and the number of TPs. Opioids administered were fentanyl TP (Durogesic, 
Janssen-CILAG, Switzerland); n = 12) at 50 (n = 6), 75 (n = 3) or 100 µg hour-1 (n = 3) and 
buprenorphine TP (Grünenthal GmbH, Germany, n = 12) at 35 (n = 6) or 70 µg hour-1  (n = 6) 
(Fig. 1). Sixteen of the 24 animals were administered a second sequential application of the    
lower dosed patches (50 or 75 µg hour-1 for fentanyl and 35 or 70 µg hour-1 for buprenorphine; 
Second series, SS). The second TP was applied 36 hours after discarding the first TP. In an  
attempt to relate potential painful behaviours with drug doses and serum concentrations, 14 of    
the 16 gilts that were administered a second patch underwent ovariectomies, before the  
application of the second TP (Fig. 1). 
 
 
Anaesthesia and surgical procedures 
 
All anaesthetic protocols were the same. After 12 hours of fasting, the animals were   
premedicated with xylazine (2 mg kg
-1
; Rompun;  Bayer Healthcare LLC, KS, USA) and 
ketamine (15 mg kg
-1
; Narketan, Vetoquinol Ltd, UK) IM. Anaesthesia was induced 20-30  
minutes later by mask with isoflurane 5% (Forene; Abbott GmbH & Co., Germany), followed by 
endotracheal intubation with a 6.0 mm silicone tracheal tube (Hi-Contour; Mallinckrodt 
Pharmaceuticals, Ireland). Anaesthesia was maintained with isoflurane in 40% oxygen using a 
vaporizer setting of 1.5-2.0%, and animals were mechanically ventilated with a  volume- 
controlled ventilator  (Siemens Servo ventilator 900D; Siemens-ELEMA AB,  Sweden). 
 
 









Cefuroxime (750 mg; Zinacef; GlaxoSmithKline, Switzerland) was administered IV 15 minutes 
prior to the skin incision. Fentanyl (30 µg kg-1 hour-1; Syntenyl; Sintetica SA, Switzerland) was 
infused only during the catheter insertion, and lactated Ringer’s solution (10 mL kg-1 hour-1; 
Ringerfundin; B. Braun Melsungen AG, Germany) was infused IV during all  surgeries. 
Twenty-four hours before the first TP application, with the animal under general anaesthesia, a 
16 gauge, 20 cm, single lumen catheter (Central Venous Catheterization Set CV-04301; Arrow 
International, Germany) was inserted into the external jugular vein. The jugular vein was  
exposed through a 5 cm lateral incision in the neck, the catheter inserted 2-3 cm and fixed with a 
purse string suture to the vessel wall. A subcutaneous tunnel was blunt dissected so that the 
catheter passed under the skin to exit laterally in the neck area and the external portion 
(approximately 5-6 cm) was sutured dorsally to the skin in the interscapular area.  After 
implantation, aspirin (25 mg kg
-1
; Aspégic; Sanofi-Aventis, Switzerland) was administered  once 
 
daily in the food to prevent clotting. The catheter was expected to last for the duration of the 
study and was kept in place with a postoperative barrier dressing (OPSITE; Smith & Nephew, 
UK) and a cotton mesh extending circumferentially from the head to  mid-trunk. 
The 14 ovariectomies were performed before the second TP application by the same surgeon, 
under aseptic conditions and general anaesthesia. Fentanyl infusions were not used during this 
procedure. One of the ovaries was exposed through a ventral midline incision and extracted after 
ligation of the ovarian vessels. The animals were observed 4 times a day for signs of pain 
(Appendix 1), in which case rescue analgesia was planned, with IM buprenorphine, 0.05 mg  kg
-1
, 




An area of interscapular skin of at least 10 cm
2 
(or larger depending on the size of the patch to be 
applied) was washed and the hair clipped, care taken not to cause bleeding or irritation. Twenty- 
 








four hours after this procedure, the first TPs were applied to the conscious animal on the   
prepared area, close to the catheter hub, and covered with a barrier dressing and cotton mesh as 
described earlier.  Thirty-six hours after the removal of the first patch, a second patch was   
applied in some animals, following the same protocol for the skin preparation. TPs were applied 
immediately after surgery or to the conscious animal for those who did not undergo  ovariectomy. 
 
 
Daily observation and blood sampling schedule 
 
All animals were observed for postoperative pain assessments for 10 minutes every 6 hours, 
before obtaining the blood samples. Behaviours were recorded and used in a pain assessment 
score (Harvey-Clark et al. 2000; Malavasi et al. 2006), comprising general behaviour and 
activity, gait, ambulatory activity, vocalizations, local signs of pain (determined by clinical 
examination and palpation, at the surgical site and in the area of application of the patch), 
presence of vomit and defaecation characteristics (Appendix 1). Body weights were also 
registered on days 0, 7 and 12. 
Blood was collected for measurement of drug concentrations beginning 24 hours after the venous 
catheter insertion immediately before First Series TP (Time 0). The first 10 samples were 
collected every 6 hours and the last 3 every 12 hours, that is before (0) and at 6, 12, 18, 24,  30, 
36, 42, 48, 54, 66, 78 and 90 hours after TP application. The sampling intervals were the same 
after Second Series TP application, a lapse of 36 hours passed between the removal of the first 
TP and the application of the second TP. In summary, 13 blood samples were collected during 
the FS and 26 blood samples were collected from pigs assigned to the FS and SS (Fig.  1). 
At each blood collection, the priming volume of the catheter and injection cap (0.6 mL) plus one 
more mL was withdrawn and discarded. Five mL of blood were then withdrawn and placed in  
dry sterile tubes (no EDTA or citrate). The catheter was then flushed with saline solution 0.9% 
and primed with 0.6 mL of heparinized saline (300 UI mL
-1
). Blood samples were refrigerated 
 








(8ºC) until blood clotted, then centrifuged at 30 000 g for 10 minutes and the serum harvested  
and frozen at -20 ºC until analysis. 
 
 
Fentanyl and buprenorphine analysis 
 
Concentrations of fentanyl and buprenorphine in plasma were determined by Liquid 
Chromatography-Mass Spectrometry (LC-MS-MS) (Agilent HP1100; Agilent Technologies, 
Germany) coupled to an ion trap mass spectrometer (Esquire 3000+; Bruker Daltonics, 
Germany). Quality control (QC) concentrations were at 0.1, 1 and 3 ng mL
-1  
corresponding to  2 
× Limit of Quantitation (LoQ), 50% and 80% of the calibration curve. Quantification  was 
 
performed in positive mode using the following transitions: 468.4→55.0 /472.4→59.0 for 
buprenorphine/internal standard (10 ng mL
-1 
of buprenorphine-d4) and 337.0→187.8/ 
342.0→187.8 for fentanyl/internal standard (10 ng mL-1 fentanyl-d5). An extraction with 
chlorobutane was performed after plasma was basified with 10 µL of triethylamine. Separation 
was carried out in C18 XTerra column (5 µm × 2.1 mm × 50 mm, Waters Corp, USA) at 0.3 mL 
minute
-1  
under a gradient mode. Along with the unknown samples, duplicate quality control (n  = 
3) and standards samples (n = 6) were prepared using blank plasma spiked with fentanyl or 
buprenorphine covering the expected concentration range were processed. The standard curves 
were obtained by weighted least-squares regression (weighting=1 X
-1
) of the measured peak area 
versus the analyte concentrations. The standard curves were then used to calculate  concentrations 
of the analytes in unknown and QC samples. The analytical method was fully validated and 
showed good performances in terms of accuracy (<20%) and precision calculated as intra-assay 
precision and inter-assay precision (<15%). LoQ was 0.05 ng mL
-1 
















The study was planned to have six pigs per group for the first and second patch application for  
the lower dosed patches (50 µg hour-1  fentanyl and 35 µg hour-1  buprenorphine). This sample  
size would ensure 80% and 90% powers at 5% significance if the mean between-group  
difference is respectively 1.8 and 2.1 times the common standard deviations of the outcome. The 
other groups were determined in an attempt to evaluate the absorption rates of different dosed 
patches: a group of six pigs was allocated to the 70 µg hour-1 buprenorphine patch and three 
animals per group for 75 µg hour-1  and 100 µg hour-1  fentanyl patches. Two pigs were included 
in a SS group, for the 75 µg hour-1  fentanyl patches and 70 µg hour-1  buprenorphine each  (Fig. 
1). 
 
Profiles of blood concentration of fentanyl and buprenorphine were summarized with area under 
the curve (AUC), peak serum concentration (Cmax) and time to peak concentration  (Tmax). 
AUC was calculated using the trapezoidal rule. Only AUC0-54  hours were compared using 
analysis of variance (ANOVA) for the first series and AUC 0-66 hours for the second series, since 
some pigs did not have blood samples drawn beyond this interval. Mean ± SD of these  
parameters were calculated for both fentanyl and buprenorphine. Analysis of variance was used  
to compare these parameters (AUC, Cmax and Tmax) between the different dose  groups. 
Separate analysis was done for the periods of the first and second patch. Non-parametric  analysis 
 
of variance was performed for Cmax and Tmax when, due to small sample, size normality 
assumption did not appear to be valid. Kruskal-Wallis test was used to test the null hypothesis of 
three dose groups under the same distribution. Pair-wise comparisons were performed using 
Wilcoxon Rank sum test. All calculations were performed using the Statistical Analysis System 


















Twelve pigs were administered a first application of either 50 µg hour-1  (n = 6), 75 µg hour-1  (n  = 
3) or 100 µg hour-1 (n = 3) fentanyl TP. Serum concentrations of fentanyl were detected for the three 
patch strengths. The application of a second patch (50 µg hour-1, n = 6; 75 µg hour-1, n = 2)  in eight 
animals also provided detectable serum concentrations, but in lower range than the first patches. 
Cmax were higher for the first 50 and 75 µg hour-1 patches applied than for the second corresponding 
patch (Table 1). AUC was higher after TP 75 or 100 µg hour-1 than after 50 µg hour-1 for the first 
and second patches (Fig. 2). Some sample results are missing because the catheters became 
dislodged, therefore, to include the maximum number of samples in  the  analysis, the AUC 0-54 
hours was calculated for the first patch and AUC  0-66 hours for the second patch. In the first series, 
differences between TP 50 µg hour-1 and 75 µg hour-1 were significant (p = 0.0017) and between TP 
50 µg hour-1 and 100 µg hour-1 (p = 0.0006) (Fig. 2). There was no significant difference in AUC 
between TP 75 and 100 µg hour-1 (p =  0.24). Individual profiles of serum fentanyl concentrations 
showed a wide variation between animals,  and between series 1 and 2 (Fig. 3). 
Buprenorphine  analysis 
 
Serum concentrations of buprenorphine were not detected in any of the six animals administered the 
lower buprenorphine TP (35 µg hour-1), either for the first or second application. The remaining six 
animals were administered one (n = 6) or two sequential (n = 2) higher dose buprenorphine TP (70 
µg hour-1) patches (Fig. 1). The first TP resulted in a large inter-individual variability for 
concentration, distribution and magnitude Fig. 4), with Tmax varying between subjects: 18 hours (n 
= 1), 24 hours (n = 3), 30 hours (n  = 1) and 42  hours (n = 1) after  application (average 0.3 ± 0.2 
ng mL
-1 
at 33 hours). Great variability in serum concentrations (0.38-0.63 ng mL
-1
) were measured 
in the two pigs that had a second buprenorphine TP (70 µg hour-1) applied. There were residual 
serum concentrations of buprenorphine from the first patch applied (0.12-0.17 ng mL
-1
). Cmax was 
 
 








attained 12 hours after application and concentrations rapidly decreased after 18 hours. 
 
 
Daily observations, blood sampling and patch  application 
 
The acclimatization period for the animals facilitated handling and daily observations. The 
indwelling catheters facilitated the blood sampling process, however not all remained patent for the 
entirety of the study. The average patency was 11.3 ± 1.6 samples in the FS and 25.2 ± 2.2 samples 
in the SS. Failure of blood collection was the result of different circumstances. Two catheters were 
pulled out, although no bleeding or hematoma were observed. Two other catheters were obstructed 
by blood clots and attempts to restore patency were unsuccessful. No infections  or local lesions 
were observed at any of the catheter insertion sites and none of the animals  showed signs of local 
pain on palpation. The exterior injection hubs remained secure and clean  and were easy to access. 
All TPs remained appropriately fixed to the interscapular skin, and were effectively protected by the 
barrier dressing. No skin irritation or sign of discomfort was observed. The larger buprenorphine TP 
(70 µg hour-1),  with a contact area of 50 cm2, was more difficult to apply in   the study pigs, 
particularly in the awake animal. The application of the fentanyl TP was simple    for the three doses, 
as the size of the larger patch (42 cm
2 





Defaecation occurred normally and no depression, hyperexcitability, aggression or other opioid 
or pain related side or adverse effects were observed. The behaviour registered for the animals 
that underwent ovariectomies did not differ significantly from those not ovariectomized. No 
rescue analgesia was administered.  Weight increased in all animals, with mean weights of  27.8 
















The serum concentrations measured after application of fentanyl TPs to pigs showed the   
presence of fentanyl for all three patch strengths (50, 75 and 100 µg hour-1), both with the first  
and the second application of a patch. Plasma concentrations obtained in the present study for the 
50 µg hour-1  TP concur with those reported previously by several authors.   Harvey-Clark et  al. 
(2000) studied the efficacy of 25 (n = 4) and 50 µg hour-1  (n = 2) TP of fentanyl in swine  with 
comparable weight to those in the present study, with only the 50 µg hour-1 patches providing 
concentrations above the 0.5 ng mL
-1 
human threshold that the authors used for comparison. 
Large inter individual variations in the observed plasma concentrations were reported, but  the 
authors concluded nevertheless that the 50 µg hour-1 TP can provide adequate basal analgesia 
(Harvey-Clarke et al. 2000). Malavasi et al. (2005) studied the effect of 50 µg hour-1 fentanyl TP 
on the activity of growing pigs (average weight 25.4 ± 5.2 kg). Serum fentanyl measurements  
after 24 hours were 0.27 ± 0.11 ng mL-1 (n = 8) and 0.47 ± 0.40 ng mL-1 (n = 8). They concluded 
that transdermal fentanyl can be absorbed, but the wide variation of serum concentrations renders 
the use of fentanyl patches unpredictable and potentially deficient in swine. Royal et al. (2013) 
reported serum concentrations of fentanyl after application of 50 µg hour-1 patches in 19 pigs 
weighing an average of 38.3 kg. The average serum concentrations measured at 24, 48 and 72 
hours after application were 0.31 ± 0.07 ng mL-1, 0.21 ± 0.05 ng mL-1 and 0.12 ± 0.02 ng mL-1, 
respectively, thus the authors suggested that therapeutic concentrations were not reached. These 
concentrations were lower than the Cmax of 0.43 ng mL
-1  
obtained in the present  study. 
No publication of use of 75 µg hour-1  fentanyl TP in swine was found in the literature. In  our 
study, the Cmax of 1.28 ± 0.84 ng mL-1 obtained 6 hours after the application of the first patch, 
was above the reported efficacy reference ranges, suggesting that 75 µg hour-1 TP could provide 
sufficient analgesic relief in swine in the weight range of 25-30  kg. 
Wilkinson et al. (2001) applied 100 µg hour-1 fentanyl TP in six Yucatán mini pigs weighing 17- 
 
 








22 kg. The authors proposed a therapeutic range extrapolated from various species of 0.2-3.0 ng 
mL
-1
, and reported peak serum concentrations ranging from 0.38 to 0.99 ng mL
-1
, between 42 
hours (n = 5) and 48 hours (n = 1), suggesting that the absorption of transdermal fentanyl at this 
dose could be effective. Although the animals in the present study had higher body weights, 
results showed much higher fentanyl concentrations at 6 hours after application of 100 µg hour-1 
TP (2.16 ng mL
-1
; n = 3), and the mean plasma concentrations were above the reference value 
over the following 48 hours. While these observations are limited to a small number of  animals, 
the lack of potential secondary effects related to higher opioid doses suggests that further studies 
should focus on the 75 µg hour-1  and 100 µg hour-1  fentanyl TP. 
The application of a second 50 µg hour-1  or 75 µg hour-1  TP provided the unexpected results  of 
 
serum fentanyl concentrations lower than those obtained with the first patch. A study of the 
sequential application of opioid TPs in swine has not been reported and further investigations 
should address this practice in clinical and experimental  settings. 
In the present study, no serum buprenorphine concentrations were detected in a 28 kg pig after 
application of a buprenorphine TP (35 µg hour-1), neither with the first nor the second  
application. These results differ from those described by Thiede et al. (2014), who reported 
maximum concentrations of 0.6 ± 0.1 ng mL-1  in five Göttingen mini pigs (weight range  12.6-27 
kg), following the application of 30 µg hour-1 buprenorphine  TP. 
The first application of 70 µg hour-1 buprenorphine TP to the pigs in this study resulted in 
detectable serum concentrations of buprenorphine, mean concentration 0.3 ± 0.2 ng mL-1 at 33 
hours. After application of the second TP, the Cmax was attained much faster, at 12 hours. This 
possibly represents a more rapid release of buprenorphine, perhaps potentiated by  drug 
accumulation in the subcutaneous fat. However, the results are from only two pigs and the range 
of concentrations was wide. 
The differences between the results reported here and those previously published (Wilkinson et 
 








al. 2001; Malavasi et al. 2005, 2006; Thiede et al. 2014) emphasize the importance of potential 
confounders. Absorption from a TP can be influenced by poor adherence to the skin, the 
composition of the skin that will be influenced by the breed and anatomical location and the 
inter-individual diversity in the kinetics of the molecule. The interscapular area was chosen for 
TP application in this study because it is a site with limited access by the pig thus reducing  the 
possibility of accidental removal, yet the area provides an adequate space to accommodate the 
bigger patches. Absorption was not notably affected when compared with other studies 
(Malavasi et al. 2005, 2006). 
A local increase in blood flow will increase fentanyl absorption from a TP, such as may occur 
when a pig is lying on a patch on a heating pad. This was not an issue with the present study 
because the TP was applied after surgery. 
Excitement should be avoided during handling of the pigs during collection of blood samples. 
While 3 days for acclimatization may seem short (Swindle & Smith 2013), the pigs in this study 
quickly adjusted to the investigators and the repetition of handling gestures with apparent 
minimum of stress and no restraint was needed. Both indwelling catheters (Zanella & Mendl 
1992; Lombardo et al. 2010) and vascular access ports (Chuang et al. 2005; Swindle et al. 2005; 
Ege et al. 2006) are used for repeated blood sampling in swine. The indwelling catheters in this 
study remained patent for on average 11 out of 13 samples in the first series and on average for 
25 out of 26 samples in the second series, with no observable indications of infection over 7  
days. 
Study limitations include the small sample size and different numbers of animals among the 
groups, which could influence the statistical analysis and the validation of the observations. 
Further, the investigators were not blinded to the type of opioid administered during observations 
of the pigs and that could have influenced the pain scores. No significant differences in the 
behaviour of the animals before and after ovariectomy were recorded, however the observations 
 
 








were made every 6 hours and a shorter interval between assessments may have identified some 
differences. Alternatively, the pain scoring system may not be a sufficiently sensitive indicator of 
pain in pigs, particularly considering the lack of serum buprenorphine concentrations in the  six 
ovariectomized pigs administered 35 µg hour-1 TPs. Further studies using more detailed pain 





Serum concentrations of fentanyl and buprenorphine were measured after transdermal patch 
application; fentanyl at 50, 75 and 100 µg hour-1, and buprenorphine at 35 and 70 µg hour-1. The 
serum concentrations of fentanyl after doses of 75 or 100 µg hour-1 to pigs weighing 25-30 kg 
were within the target range suggested to provide analgesia for up to 48 hours. No vomiting or 
diarrhoea was observed and the pigs continued to gain  weight. 
The absence of serum concentrations of buprenorphine following the application of 35 µg hour-1 
patches prevents us from recommending its use in pigs in this weight range. Owing to the broad 
variations encountered in serum concentrations following the application of 70 µg  hour-1 
buprenorphine patches, additional studies are needed before recommending its use as sole 
method of pain control in the laboratory pig. 
Sequential applications of fentanyl or buprenorphine TP did not provide reliable serum 
concentrations; and these results do not support this method of TP use for long-term analgesia in 
the pig. Further pharmacokinetics studies and analgesiometric tests are required to confirm the 
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Table  1  Time  (Tmax)  to  peak  serum  concentrations  (Cmax)  of     fentanyl  after application  of 
 

















1.28 ± 0.84 
 
(n = 3) 
0.45 ± 0.08 
36 






2.16 ± 1.46 
 





















0.43 ± 0.18  
30 
0.26 ± 0.02 
  (n = 6)  (n = 6) 
 











Appendix 1 Pain assessment 
 
Recorded behaviour Score Description 
General behaviour + to +++ Responds to handler, alert, 




+ to +++ 
 


































Local sign of pain 
 
Yes/No Redness, bleeding, swelling, 




+, low pain; +++, high pain 
 













Figure 1 Timeline and subject randomization for application of fentanyl and buprenorphine 
transdermal patches (TP) in 24 Yorkshire gilts weighing a mean of 27.8 kg. n = number of  pigs. 
 
Figure 2 Serum fentanyl concentrations expressed as area under the curve (AUC) of different 
strengths of fentanyl patches applied to pigs:   AUC1 is the mean AUC over 0-54 hours in the   first 
series for patches 50 µg mL-1 (n = 6), 75 µg mL-1  (n = 3) or 100 µg mL-1 (n = 3), and  AUC2  is the 




Figure 3 Individual profiles of the serum fentanyl concentrations (ng mL
-1
) in pigs for the first 
and second transdermal patch (TP) application. For the first TP: 50 µg hour-1 (__) (n = 6), 75 µg 
hour
-1 
(--) (n = 3), 100 µg hour-1 (.…) (n = 3). Eight pigs were administered a second TP 36 hours 
after the first patch was removed: 50 µg hour-1  (n = 6) and 75 µg hour-1  (n = 2). 
 
Figure 4 Individual profiles for six pigs of serum buprenorphine concentrations (ng mL
-1
)  
before and after application of the first 70 µg hour-1 patch. Values below the 0.05 ng mL-1 limit 
of quantification are not indicated. 
 























































My heartfelt thanks to Dr. med. vet. Peter Kronen and Prof. Dr. Walid Habre for their 
mentoring and support, this project would have not been possible without your help. 
 
 My most sincere thanks to Prof Dr. med. vet. Brigitte von Rechenberg for her invaluable 
and generous guidance.   
 
My deep gratitute to Dr. Mustafa Cikirikcioglou, Mme Sylvie Roulet and Mr Manuel 
Costa for their friendship and invaluable logistical help. 
 
My sincere thanks to Ms Silvia Kaufmann, for her patience and administrative guidance 
through this study. 
 
Last but not least, my immense gratitude to my husband, Ed, for being there at each step 
of the way, with love, good advice and endless support.






Vorname Name  Suzanne Marie Osorio Lujan 
Geburtsdatum   06/06/1963 
Geburtsort   San Jose, Costa Rica 
Nationalität   Portugal 
03/1968-11/1980  Lycée Franco Costaricien. San José, Costa Rica 
05/12/1980 Baccalaureat ès Sciences, Lycée Franco Costaricien, San 
José, Costa Rica 
03/1981-11/1987 Veterinary Studies, Universidad Nacional de Costa Rica, 
Heredia, Costa Rica 
 
17/08/1988  Licenciate degree in Veterinary Medicine. Thesis 
presentation: “Estudio epidemiológico sobre diarreas y 
problemas respiratorios en terneros de leche de 0 a 3 meses 
de edad”, Universidad Nacional de Costa Rica, in 
collaboration with the School of Veterinary Medicine, 
University of  Davis, California, U.S.A  
 
01/2006-04/2017 Anfertigung der Dissertation unter der Leitung von  
Prof. med. vet. Brigitte von Rechenberg, Musculoskeletal 
Research Unit (MSRU) am Institut für Molekulare 
Mechanismen bei Krankheiten der Vetsuisse-Fakultät 
Universität Zürich 
08/1989- 07/1992 Stage at the Service de Pathologie Infectieuse, at the  
« Institut d’Élevage et de Médecine Vétérinaire des Pays 
Tropicaux (I.E.M.V.T.-C.I.R.A.D.) ». Maisons Alfort, 
France. 
 
08/2004-07/2007 Research Assistant, Department of Surgery, Service of 
Cardiovascular Surgery, University Hospital, Geneva, 
Switzerland. 
 
08/2007-01/2010 Research Instructor, Department of Pediatrics, Section of 
Pediatric Cardiology, University of Colorado School of 
Medicine, Denver,  Colorado, USA. 
 
01/2010-present Assistant Professor, Department of Pediatrics, Section of 
Pediatric Cardiology, University of Colorado School of 
Medicine, Denver,  Colorado, USA. 
 
